Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Additional Registration Fee
Invitation Only
Student Program
Networking Opportunity
RAPS Focus Area
Browse by Presenter
Home
Browse by Presenter
*Program and presenters subject to change. Please check back frequently for updates.
Browse by Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
L
Laan, Alex
BSI Group The Netherlands B.V.
IVDR Technical Documentation Pre-conference Workshop
Location/Room:511F
Alex Laan
Favorite
IVDR Transition and Implementation: What Have We Learned from the MDR?
Location/Room:511F
Alex Laan
Favorite
Solutions Circle: Notified Bodies: IVDR implementation Ask me Anything
Location/Room:Exhibit Hall: Solutions Circles
Alex Laan
Favorite
What can Legacy Manufacturers Learn from Effective PMS and PMPF Implementation in Order to Prepare to Become IVDR compliant?
Location/Room:510A
Alex Laan
Favorite
Langevin, Nicholas
Sumitomo Pharma America, Inc.
Maximizing the Impact of Patient-centric Data: Meaningful Interactions Informing Regulatory Decision-making.
Location/Room:513B
Nicholas Langevin
Favorite
Larsson, Kristina
European Medicines Agency
Decoding Orphan Drug development: Bridging Boundaries and Thinking “Outside the Box”
Location/Room:513D
Kristina Larsson
Favorite
Laslop, Andrea
Austrian Medicines and Medical Devices Agency
Conversations That Matter - Interactions with Health Authorities: Drugs, Biologics and Combination Products
Location/Room:511E
Andrea Laslop
Favorite
Drug Development in EU: Regulatory Standards, Support and New Approaches
Location/Room:510B
Andrea Laslop
Favorite
Ensuring Patient Registries Support Regulatory Decision-Making
Location/Room:510B
Andrea Laslop
Favorite
Health Authority Forum: European Medicines Agency (EMA)
Location/Room:510B
Andrea Laslop
Favorite
Leander, Niels
NNIT
Solutions Circle: 5 Ways that an RA Department Will be Impacted by IDMP Data Standards
Location/Room:Exhibit Hall: Solutions Circles
Niels Leander
Favorite
Lee, Jill
Novo Nordisk
FDA Expectations for using Digital Tools in Decentralized Clinical Trials
Location/Room:513D
Jill Lee
Favorite
Solutions Circle: FDA Expectations for Digital Health Tools in Decentralized Clinical Trials
Location/Room:Exhibit Hall: Solutions Circles
Jill Lee
Favorite
Lehoczki, Arpad
GlobalVision
Sponsored Presentation: How AI will Power the Future of Proofreading in Pharma
Location/Room:Exhibit Hall: Discover! Stage (Booth 123)
Arpad Lehoczki
Favorite
Lejcher, Marielle
Fang Consulting
Sponsored Presentation: Risk Strategy & Risk Management for Medical Devices
Location/Room:Exhibit Hall: Ignite! Stage (Booth 623)
Marielle Lejcher
Favorite
Liberti, Lawrence
RAPS BOD Roundtable: I Am Regulatory
Location/Room:RAPS Central (Exhibit Hall: Booth #610)
Lawrence Liberti
Favorite
RAPS BOD Roundtable: Volunteering
Location/Room:RAPS Central (Exhibit Hall: Booth #610)
Lawrence Liberti
Favorite
Li, Jingrui
The University of Southern California
Student Capstone Oral Presentation: Australia Market Access Strategy of Novel Drug with Companion Diagnostic Test Kit for Breast Cancer
Location/Room:Exhibit Hall: Career Central (Booth 633)
Jingrui Li
Favorite
Lin, Rita
Agilis by Kymanox
When to “Factor” in Human Factors
Location/Room:511E
Rita Lin
Favorite
Loh, Evangeline
Emergo by UL
International Regulator Forum
Location/Room:510B
Evangeline Loh
Favorite
Lozito, Antonella
Moderna
Regulatory Opportunities and Challenges with mRNA Technology – Lessons Learned from the COVID-19 Pandemic
Location/Room:511D
Antonella Lozito
Favorite
